Prospective observational study to determine the accuracy of first-trimester serum biomarkers and uterine artery Dopplers in combination with maternal characteristics and arteriography for the prediction of women at risk of preeclampsia and other adverse pregnancy outcomes

References

• Akolekar R, Syngelaki A, Sarquis R, et al. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn. 2011;31(1):66–74.
   PubMed Web of Science ®Google Scholar
• RCOG. The investigation and management of the small for gestational age fetus. Green top guideline number 312013.
   Google Scholar
• Kuc S, Wortelboer EJ, van Rijn BB, et al. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv. 2011;66(4):225–239.
   PubMed Web of Science ®Google Scholar
• Allen R, Marleen S, Velauthar L, et al. Improved early prediction of preterm preeclampsia by combining second trimester maternal serum alpha fetoprotein and uterine artery Doppler. Journal of clinical. Gynecol Obstet. 2014;3(1):22–29.
   Google Scholar
• Allen R, Marleen S, Velauthar L, et al. The relationship between second trimester alpha fetoprotein levels and adverse pregnancy outcome. Open J Obstet Gynecol. 2013;3:262–266.
   Google Scholar
• Allen RE, Rogozinska E, Cleverly K, et al. Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2014;182:194–201.
   PubMed Web of Science ®Google Scholar
• Costa SL, Proctor L, Dodd JM, et al. Screening for placental insufficiency in high-risk pregnancies: is earlier better? Placenta. 2008;29(12):1034–1040.
   PubMed Web of Science ®Google Scholar
• Khalil A, Akolekar R, Syngelaki A, et al. Maternal hemodynamics in normal pregnancies at 11–13 weeks’ gestation. Fetal Diagn Ther. 2012;32(3):179–185.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Zaragoza E, Poon LCY, et al. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32(6):732–739.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Minekawa R, Veduta A, et al. Maternal plasma inhibin A at 11–13 weeks of gestation in hypertensive disorders of pregnancy. Prenat Diagn. 2009;29(8):753–760.
   PubMed Web of Science ®Google Scholar
• Dugoff L, Hobbins JC, Malone FD, et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol. 2004;191(4):1446–1451.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Tuuli M, Odibo AO. First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction. Prenat Diagn. 2010;30(4):293–308.
   PubMed Web of Science ®Google Scholar
• Goetzinger KR, Singla A, Gerkowicz S, et al. Predicting the risk of pre-eclampsia between 11 and 13 weeks’ gestation by combining maternal characteristics and serum analytes, PAPP-A and free beta-hCG. Prenat Diagn. 2010;30(12–13):1138–1142.
   PubMed Web of Science ®Google Scholar
• Poon LCY, Maiz N, Valencia C, et al. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol. 2009;33(1):23–33.
   PubMed Web of Science ®Google Scholar
• Spencer K, Yu CK, Cowans NJ, et al. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn. 2005;25(10):949–953.
   PubMed Web of Science ®Google Scholar
• Odibo AO, Zhong Y, Goetzinger KR, et al. First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia. Placenta. 2011;32(8):598–602.
   PubMed Web of Science ®Google Scholar
• Yaron Y, Ochshorn Y, Heifetz S, et al. First trimester maternal serum free human chorionic gonadotropin as a predictor of adverse pregnancy outcome. Fetal Diagn Ther. 2002;17(6):352–356.
   PubMed Web of Science ®Google Scholar
• Madazli R, Bulut B, Tuten A, et al. First-trimester maternal serum metastin, placental growth factor and chitotriosidase levels in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2012;164(2):146–149.
   PubMed Web of Science ®Google Scholar
• Noori M, Donald AE, Angelakopoulou A, et al. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation. 2010;122(5):478–487.
   PubMed Web of Science ®Google Scholar
• Vatten LJ, Åsvold BO, Eskild A. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction. Acta Obstet Gynecol Scand. 2012;91(12):1388–1394.
   PubMed Web of Science ®Google Scholar
• Wortelboer EJ, Koster MP, Cuckle HS, et al. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia. BJOG. 2010;117(11):1384–1389.
   PubMed Web of Science ®Google Scholar
• Dugoff L, Hobbins JC, Malone FD, et al. FASTER Trial Research Consortium. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol. 2005;106(2):260–267.
   PubMed Web of Science ®Google Scholar
• Walters BN, Lao T, Smith V, et al. Alpha-fetoprotein elevation and proteinuric pre-eclampsia. BJOG. 1985;92(4):341–344.
   Google Scholar
• Williams MA, Hickok DE, Zingheim RW, et al. Elevated maternal serum alpha fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes. Am J Obstet Gynecol. 1992;167(4 Pt 1):1032–1037.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683.
   PubMed Web of Science ®Google Scholar
• Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res. 2004;95(9):884–891.
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–658.
   PubMed Web of Science ®Google Scholar
• Stepan H, Unversucht A, Wessel N, et al. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension. 2007;49(4):818–824.
   PubMed Web of Science ®Google Scholar
• Khalil A, Akolekar R, Syngelaki A, et al. Maternal hemodynamics at 11–13 weeks’ gestation and risk of pre-eclampsia. Ultrasound Obstet Gynecol. 2012;40(1):28–34.
   PubMed Web of Science ®Google Scholar
• Poon LC, Kametas NA, Maiz N, et al. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension. 2009;53(5):812–818.
   PubMed Web of Science ®Google Scholar
• Khalil A, Sodre D, Syngelaki A, et al. Maternal hemodynamics at 11–13 weeks of gestation in pregnancies delivering small for gestational age neonates. Fetal Diagn Ther. 2012;32(4):231–238.
   PubMed Web of Science ®Google Scholar